se ha leído el artículo
array:21 [ "pii" => "X0211699512000663" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2011.Dec.11246" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2012;32:270-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5139 "formatos" => array:3 [ "EPUB" => 308 "HTML" => 4179 "PDF" => 652 ] ] "Traduccion" => array:1 [ "en" => array:17 [ "pii" => "X2013251412000660" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Dec.11246" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2012;32:270-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4895 "formatos" => array:3 [ "EPUB" => 294 "HTML" => 3903 "PDF" => 698 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "C1q Nephropathy and Malignancy" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "270" "paginaFinal" => "272" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11246_16025_23512_en_f1_11246.jpg" "Alto" => 1068 "Ancho" => 1392 "Tamanyo" => 1272556 ] ] "descripcion" => array:1 [ "en" => "Kidney biopsy specimen." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sofia Rocha, M. João Carvalho, Luísa Lobato, Josefina Santos, Guilherme Rocha, Ramón Vizcaíno, António Cabrita" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Sofia" "apellidos" => "Rocha" ] 1 => array:2 [ "nombre" => "M. João" "apellidos" => "Carvalho" ] 2 => array:2 [ "nombre" => "Luísa" "apellidos" => "Lobato" ] 3 => array:2 [ "nombre" => "Josefina" "apellidos" => "Santos" ] 4 => array:2 [ "nombre" => "Guilherme" "apellidos" => "Rocha" ] 5 => array:2 [ "nombre" => "Ramón" "apellidos" => "Vizcaíno" ] 6 => array:2 [ "nombre" => "António" "apellidos" => "Cabrita" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X0211699512000663" "doi" => "10.3265/Nefrologia.pre2011.Dec.11246" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512000663?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000660?idApp=UINPBA000064" "url" => "/20132514/0000003200000002/v0_201502091616/X2013251412000660/v0_201502091617/en/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X0211699512001038" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2012.Jan.11340" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2012;32:273-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 21801 "formatos" => array:3 [ "EPUB" => 279 "HTML" => 20917 "PDF" => 605 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Valoración de la nueva ecuación CKD-EPI para la estimación del filtrado glomerular" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "273" "paginaFinal" => "274" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Assessment of the new CKD-EPI equation to estimate the glomerular filtration rate" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11340_16025_25639_es_t1_fe.jpg" "Alto" => 1318 "Ancho" => 1091 "Tamanyo" => 704914 ] ] "descripcion" => array:1 [ "es" => "Ecuación de estimación del filtrado glomerular CKD-EPI" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rosario Montañés-Bermúdez" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Rosario" "apellidos" => "Montañés-Bermúdez" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251412001035" "doi" => "10.3265/Nefrologia.pre2012.Jan.11340" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412001035?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512001038?idApp=UINPBA000064" "url" => "/02116995/0000003200000002/v0_201502091353/X0211699512001038/v0_201502091354/es/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X021169951200068X" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2011.Dec.11154" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2012;32:266-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 8708 "formatos" => array:3 [ "EPUB" => 304 "HTML" => 7787 "PDF" => 617 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Aplasia medular en paciente con nefropatía lúpica terminal y c-ANCA (+)" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "266" "paginaFinal" => "268" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Medullary aplasia in c-ANCA positive patient with end-stage lupus nephritis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "11154_108_21054_es_11154_f1.jpg" "Alto" => 381 "Ancho" => 600 "Tamanyo" => 269860 ] ] "descripcion" => array:1 [ "es" => "Biopsia renal. Glomeruloesclerosis severa y lesión tubular" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carlos Mañero-Rodríguez, Antonio Navas-Parejo Casado, Mercedes Gómez, Raimundo García-del Moral, Antonio Osuna, Sebastián Cerezo-Morales" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Carlos" "apellidos" => "Mañero-Rodríguez" ] 1 => array:2 [ "nombre" => "Antonio" "apellidos" => "Navas-Parejo Casado" ] 2 => array:2 [ "nombre" => "Mercedes" "apellidos" => "Gómez" ] 3 => array:2 [ "nombre" => "Raimundo" "apellidos" => "García-del Moral" ] 4 => array:2 [ "nombre" => "Antonio" "apellidos" => "Osuna" ] 5 => array:2 [ "nombre" => "Sebastián" "apellidos" => "Cerezo-Morales" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251412000687" "doi" => "10.3265/Nefrologia.pre2011.Dec.11154" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412000687?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169951200068X?idApp=UINPBA000064" "url" => "/02116995/0000003200000002/v0_201502091353/X021169951200068X/v0_201502091354/es/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "C1q Nephropathy and Malignancy" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "270" "paginaFinal" => "272" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Sofia Rocha, M. João Carvalho, Luísa Lobato, Josefina Santos, Guilherme Rocha, Ramón Vizcaíno, António Cabrita" "autores" => array:7 [ 0 => array:4 [ "nombre" => "Sofia" "apellidos" => "Rocha" "email" => array:1 [ 0 => "sofiarocha81@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "nombre" => "M. João" "apellidos" => "Carvalho" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 2 => array:3 [ "nombre" => "Luísa" "apellidos" => "Lobato" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "nombre" => "Josefina" "apellidos" => "Santos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "nombre" => "Guilherme" "apellidos" => "Rocha" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 5 => array:3 [ "nombre" => "Ramón" "apellidos" => "Vizcaíno" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 6 => array:3 [ "nombre" => "António" "apellidos" => "Cabrita" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of Nephrology, Hospital de Santo António, Centro Hospitalar do Porto, Porto, Portugal, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Department of Pathology, Hospital de Santo António, Centro Hospitalar do Porto, Porto, Portugal, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "C1q Nephropathy and Malignancy" ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Dear Editor,</span></p><p class="elsevierStylePara">C1q nephropathy (C1qN) is an idiopathic glomerular disease characterized by extensive mesangial deposition of C1q with associated mesangial immune complexes, in the absence of evidence of systemic lupus erythematosus.<span class="elsevierStyleSup">1</span></p><p class="elsevierStylePara">The prevalence of C1qN has been estimated from 0.2% to 16%.<span class="elsevierStyleSup">1-9</span> Light microscopy (LM) findings range from no glomerular abnormalities to mesangial proliferation<span class="elsevierStyleSup">1,6-9,11,12</span> or focal segmental glomerulosclerosis (FSG).<span class="elsevierStyleSup">2-4,6-8,13</span> Clinical presentations vary from asymptomatic urinary anomalies,<span class="elsevierStyleSup">5,7,8,11,13</span> and macroscopic hematuria,<span class="elsevierStyleSup">14</span> to nephritic syndrome<span class="elsevierStyleSup">3,15</span> and corticorresistent nephrotic syndrome (NS).<span class="elsevierStyleSup">1,2-4,6-8</span> Earlier reports found a poor response to steroids and a high risk of progression to end-stage renal disease (ESRD),<span class="elsevierStyleSup">1,3,6,12,15</span> particularly those with FSG. Patients presenting asymptomatic urinary anomalies have been found to have a good prognosis.<span class="elsevierStyleSup">2-5,7,8</span> The variability in the prevalence, clinical presentation and prognosis of C1qN has been attributed to different ages and ethnicities of the patients included in the series, and to different thresholds to perform a renal biopsy.</p><p class="elsevierStylePara">The association between NS and malignancy has been reported in various glomerulopathies, but not with C1qN. Recognition of malignancy-associated glomerulopathies is important to prevent ineffective and potentially harmful treatment.</p><p class="elsevierStylePara">A 56-year-old male was admitted to our Department with NS. He reported persistent peripheral edema lasting for two months. He was a smoker of 80 packs/year. He had exuberant edema of lower extremities and abdominal wall. Laboratory findings revealed hypoalbuminemia (1.1g/dL), proteinuria (10g/day) and microscopic hematuria; serum creatinine was 1.1mg/dL and urea: 48mg/dL. Hyperlipidemia (total-cholesterol: 326mg/dL) was also noted. HBs-antigen, HCV-antibody and HIV-antibody were all negative. Serum protein electrophoresis was unremarkable; complement levels, ANCA, ANA, cryoglobulins and anti-phospholipid antibodies were normal. Ultrassonography of the kidneys was unremarkable. Abdominal ultrassonography showed small volume ascites, and chest X-ray revealed small pleural effusions, without any other abnormal findings.</p><p class="elsevierStylePara">A renal biopsy was performed, whose histological findings are shown in Figure 1. Fifteen glomeruli were observed, showing segmental thickening of glomerular basement membranes (GBM) and mesangium by an eosinophilic Congo-red negative amorphous material. Spike formation or stippling of the GBM was absent in periodic-acid methenamine-silver staining. Immunofluorescence (IF) revealed predominant presence of comma-shaped C1q mesangial deposits.</p><p class="elsevierStylePara">We started prednisolone (1mg/Kg/day), cyclosporine (3mg/Kg/day) and acenocumarol. One month later, he had an acute pyelonephritis, with worsening renal function (creatinine: 1.6mg/dL). Prednisolone dose was reduced to 0.5mg/Kg/day.</p><p class="elsevierStylePara">Two months later, his clinical condition deteriorated, with asthenia, anorexia and anasarca. Laboratory findings revealed a serum creatinine of 3.9mg/d, with proteinuria (39g/day) and hypoalbuminemia (1.1g/dL); trough levels of cyclosporine were 176ng/mL. In an attempt to reduce proteinuria, non-steroidal anti-inflammatory drugs were tried, without response. Cyclosporine was stopped and a right nephrectomy was performed. FSG was noted in all of the 15 glomeruli, with persistence of mesangial C1q deposits. It is plausible that the first biopsy was not representative, or maybe this findings represented the rapid course of the disease.</p><p class="elsevierStylePara">In the post-operative period, the patient developed signs of hyperhydration and started haemodialysis. Hypoalbuminemia and signs of hyperhidration gradually improved, but he maintained severe proteinuria. When clinical euvolemia was achieved, a right pleural effusion persisted. A CT scan was performed, revealing a disseminated neoplasm (Figure 2). A pleural exudate without malignant cells was drained. Tumor markers Ca 19.9 (95.2U/L, normal <27U/L) and neuron specific enolase (NSE) (96.6U/L, normal <15.2U/L) were elevated.</p><p class="elsevierStylePara">The patient’s general condition rapidly deteriorated with marked cachexy and, later on, respiratory failure. Invasive investigation was not possible, as the patient was not fit. A week later, he died with a nosocomial respiratory infection. Histological characterization of the neoplasm was not possible, as the patient’s family refused an autopsy.</p><p class="elsevierStylePara">C1qN can present with NS, typically with histological phenotype of either MCD or FSG. In a report of 15 pediatric patients with C1qN, 9 children had corticorresistent NS. FSG was diagnosed in four cases with poor outcome.<span class="elsevierStyleSup">3</span> Markowitz et al.<span class="elsevierStyleSup">2</span> reported 19 patients with C1qN, 79% of which with nephrotic proteinuria. Renal biopsy disclosed FSG in 17 patients and MCD in two. Four patients with FSG had progressive renal insufficiency and two developed ESRD within 27 months. In a report of 20 pediatric patients, 70% presented nephrotic range proteinuria.<span class="elsevierStyleSup">4</span> The most common histological phenotypes were FSG (40%) and MCD (30%). Patients with FSG had poor prognosis, with half progressing to ESRD in 3 years. In the report of Vizjak et al.<span class="elsevierStyleSup">7</span> comprising 72 kidney biopsies with C1qN, FSG was found in 11 patients with NS, 33% which progressed to ESRD within 2.9 years. Hisano et al.<span class="elsevierStyleSup">8</span> reported a lower prevalence of NS (41%) among 61 Japanese patients with C1qN. The prevalence of MCD in the nephrotic group was 92%, while FSG corresponded only to 8% of the cases. The majority of the patients in nephrotic group were frequent relapsers, but only 4% progressed to ESRD.</p><p class="elsevierStylePara">A paraneoplastic syndrome is usually inferred when glomerular proteinuria develops in the six months before or after the diagnosis of malignancy. In our patient, initial evaluation didn’t provide any clue to an underlying diagnosis of malignancy. His systemic manifestations were attributed to severe protein loss, as well as to prolonged periods of hospitalization. Five months after the diagnosis of NS, a right pleural effusion persisted after achievement of euvolemia, and a CT was performed showing a disseminated neoplasm. The patient’s clinical condition had markedly deteriorated and he died of sepsis and respiratory failure within a week.</p><p class="elsevierStylePara">Previous immunossupressive therapy may have triggered tumor cells, and promote the rapid and inexorable outcome. The patient was a heavy smoker, a known risk factor for several types of neoplasm, including lung and gastrointestinal tract carcinomas, the most frequently associated with paraneoplastic glomerulopathies. He also had high levels of NSE and Ca 19.9, which can be found in gastrointestinal and lung cancers.</p><p class="elsevierStylePara">Failure to recognize paraneoplastic glomerulonephritis can subject patients to ineffective and potentially harmful therapy. It is important to highlight the possible association between C1qN and malignancy. Before refractory NS associated with C1qN, an underlying malignancy should be suspected.</p><p class="elsevierStylePara"> </p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflict of interest</span></p><p class="elsevierStylePara">The authors declare that there is no conflict of interest associated with this manuscript.</p><p class="elsevierStylePara"><a href="grande/11246_16025_23512_en_f1_11246.jpg" class="elsevierStyleCrossRefs"><img src="11246_16025_23512_en_f1_11246.jpg" alt="Kidney biopsy specimen."></img></a></p><p class="elsevierStylePara">Figure 1. Kidney biopsy specimen.</p><p class="elsevierStylePara"><a href="grande/11246_16025_23513_en_f2_11246.jpg" class="elsevierStyleCrossRefs"><img src="11246_16025_23513_en_f2_11246.jpg" alt="CT scan"></img></a></p><p class="elsevierStylePara">Figure 2. CT scan</p>" "pdfFichero" => "P1-E534-S3460-A11246.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:15 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Jennette JC, Hipp CG. C1q nephropathy: a distinct clinical pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 1985;6(2):103-10. <a href="http://www.ncbi.nlm.nih.gov/pubmed/3875286" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "2.\u{A0}Markowitz G, Schwimmer J, Stokes M, Nasr S, Seigle RL, Valeri AM, et al.\u{A0} C1q nephropathy: A variant of focal segmental glomerulosclerosis. Kidney Int 2003;64:1232-40. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12969141" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "3.\u{A0}Iskandar SS, Browning MC, Lorentz WB. C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 1991;18(4):459-65. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1928065" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "4.\u{A0}Lau K, Gaber L, Santos N, Wyatt R. C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 2005;20:744-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15827744" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "5.\u{A0}Nishida M, Kawakatsu H, Okumura Y, Hamaoka K. C1q nephropathy with asymptomatic urine abnormalities. Pediatr Nephrol 2005;20(11):1669-70. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16133042" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "6.\u{A0}Kersnik LT, Kenda RB, Avgustin CM, Ferluga D, Hvala A, Vizjak A. C1Q nephropathy in children. Pediatr Nephrol 2005;20(12):1756-61. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16247648" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "7.\u{A0}Vizjak A, Ferluga D, Jennette,\u{A0}Hvala A, Lindic J, Levart TK, et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 2008;19:2237-44." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Hisano S, Fukuma Y, Segawa Y, Niimi K, Kaku Y, Hatae K, et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol 2008;3:1637-43. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18650410" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "9.\u{A0}Roberti I, Baqi N, Vyas S. A single-center study of C1q nephropathy in children. Pediatr Nephrol 2009;24:77-82. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18688655" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "10.\u{A0}Wong CS, Fink CA, Baechle J, Harris AA, Staples AO, Brandt JR. C1q nephropathy and minimal change nephrotic syndrome. Pediatr Nephrol 2009;24:761-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19082635" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "11.\u{A0}Davenport A, Maciver AG, Mackenzie JC. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome? Nephrol Dial Transplant 1992;7(5):391-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1321373" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "12.\u{A0}Sharman A, Furness P, Feehally J. Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant 2004;19:1420-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15004260" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "13.\u{A0}Fukuma Y, Hisano S, Segawa Y,\u{A0}Niimi K, Tsuru N, Kaku Y, et al. Clinicopathologic correlation of C1q nephropathy in children. Am J Kidney Dis 2006;47(3):412-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16490619" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Taggart L, Harris A, El-Dahr Samir. C1q nephropathy in a child presenting with recurrent gross hematuria. Pediatr Nephrol 2010;25:165-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19669167" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "15.\u{A0}Srivastava T, Chadha V, Taboada EM, Alon US. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol 2000;14(10-11):976-9." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/02116995/0000003200000002/v0_201502091353/X0211699512000663/v0_201502091354/en/main.assets" "Apartado" => array:4 [ "identificador" => "35346" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas al Director - Casos clínicos breves" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02116995/0000003200000002/v0_201502091353/X0211699512000663/v0_201502091354/en/P1-E534-S3460-A11246.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512000663?idApp=UINPBA000064" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 7 | 7 | 14 |
2024 Octubre | 54 | 30 | 84 |
2024 Septiembre | 41 | 25 | 66 |
2024 Agosto | 70 | 48 | 118 |
2024 Julio | 60 | 27 | 87 |
2024 Junio | 61 | 39 | 100 |
2024 Mayo | 80 | 35 | 115 |
2024 Abril | 52 | 40 | 92 |
2024 Marzo | 39 | 25 | 64 |
2024 Febrero | 46 | 30 | 76 |
2024 Enero | 34 | 26 | 60 |
2023 Diciembre | 44 | 30 | 74 |
2023 Noviembre | 44 | 29 | 73 |
2023 Octubre | 39 | 24 | 63 |
2023 Septiembre | 51 | 30 | 81 |
2023 Agosto | 27 | 19 | 46 |
2023 Julio | 44 | 26 | 70 |
2023 Junio | 41 | 21 | 62 |
2023 Mayo | 51 | 36 | 87 |
2023 Abril | 22 | 15 | 37 |
2023 Marzo | 29 | 26 | 55 |
2023 Febrero | 20 | 28 | 48 |
2023 Enero | 42 | 31 | 73 |
2022 Diciembre | 36 | 37 | 73 |
2022 Noviembre | 43 | 34 | 77 |
2022 Octubre | 44 | 29 | 73 |
2022 Septiembre | 29 | 30 | 59 |
2022 Agosto | 39 | 44 | 83 |
2022 Julio | 29 | 39 | 68 |
2022 Junio | 31 | 26 | 57 |
2022 Mayo | 50 | 45 | 95 |
2022 Abril | 44 | 38 | 82 |
2022 Marzo | 43 | 46 | 89 |
2022 Febrero | 40 | 40 | 80 |
2022 Enero | 34 | 31 | 65 |
2021 Diciembre | 41 | 42 | 83 |
2021 Noviembre | 34 | 39 | 73 |
2021 Octubre | 29 | 51 | 80 |
2021 Septiembre | 32 | 35 | 67 |
2021 Agosto | 27 | 43 | 70 |
2021 Julio | 26 | 32 | 58 |
2021 Junio | 28 | 20 | 48 |
2021 Mayo | 38 | 25 | 63 |
2021 Abril | 74 | 31 | 105 |
2021 Marzo | 46 | 21 | 67 |
2021 Febrero | 35 | 36 | 71 |
2021 Enero | 39 | 20 | 59 |
2020 Diciembre | 26 | 11 | 37 |
2020 Noviembre | 23 | 18 | 41 |
2020 Octubre | 17 | 20 | 37 |
2020 Septiembre | 21 | 12 | 33 |
2020 Agosto | 36 | 17 | 53 |
2020 Julio | 26 | 14 | 40 |
2020 Junio | 32 | 16 | 48 |
2020 Mayo | 36 | 9 | 45 |
2020 Abril | 28 | 15 | 43 |
2020 Marzo | 30 | 11 | 41 |
2020 Febrero | 32 | 18 | 50 |
2020 Enero | 34 | 15 | 49 |
2019 Diciembre | 34 | 31 | 65 |
2019 Noviembre | 26 | 20 | 46 |
2019 Octubre | 14 | 11 | 25 |
2019 Septiembre | 32 | 30 | 62 |
2019 Agosto | 18 | 19 | 37 |
2019 Julio | 16 | 21 | 37 |
2019 Junio | 31 | 19 | 50 |
2019 Mayo | 26 | 36 | 62 |
2019 Abril | 48 | 54 | 102 |
2019 Marzo | 37 | 18 | 55 |
2019 Febrero | 36 | 15 | 51 |
2019 Enero | 26 | 12 | 38 |
2018 Diciembre | 76 | 33 | 109 |
2018 Noviembre | 105 | 17 | 122 |
2018 Octubre | 95 | 16 | 111 |
2018 Septiembre | 72 | 12 | 84 |
2018 Agosto | 60 | 13 | 73 |
2018 Julio | 63 | 14 | 77 |
2018 Junio | 54 | 15 | 69 |
2018 Mayo | 65 | 11 | 76 |
2018 Abril | 54 | 11 | 65 |
2018 Marzo | 52 | 18 | 70 |
2018 Febrero | 45 | 14 | 59 |
2018 Enero | 42 | 6 | 48 |
2017 Diciembre | 40 | 9 | 49 |
2017 Noviembre | 55 | 12 | 67 |
2017 Octubre | 35 | 3 | 38 |
2017 Septiembre | 38 | 14 | 52 |
2017 Agosto | 36 | 8 | 44 |
2017 Julio | 49 | 12 | 61 |
2017 Junio | 64 | 16 | 80 |
2017 Mayo | 64 | 10 | 74 |
2017 Abril | 44 | 8 | 52 |
2017 Marzo | 57 | 12 | 69 |
2017 Febrero | 42 | 9 | 51 |
2017 Enero | 47 | 6 | 53 |
2016 Diciembre | 84 | 6 | 90 |
2016 Noviembre | 95 | 11 | 106 |
2016 Octubre | 104 | 14 | 118 |
2016 Septiembre | 184 | 1 | 185 |
2016 Agosto | 236 | 1 | 237 |
2016 Julio | 218 | 9 | 227 |
2016 Junio | 139 | 0 | 139 |
2016 Mayo | 103 | 0 | 103 |
2016 Abril | 88 | 0 | 88 |
2016 Marzo | 96 | 0 | 96 |
2016 Febrero | 130 | 0 | 130 |
2016 Enero | 114 | 0 | 114 |
2015 Diciembre | 141 | 0 | 141 |
2015 Noviembre | 116 | 0 | 116 |
2015 Octubre | 96 | 0 | 96 |
2015 Septiembre | 87 | 0 | 87 |
2015 Agosto | 107 | 0 | 107 |
2015 Julio | 103 | 0 | 103 |
2015 Junio | 53 | 0 | 53 |
2015 Mayo | 110 | 0 | 110 |
2015 Abril | 27 | 0 | 27 |